Cello Health Limited
Cello Health Limited, headquartered in Great Britain, is a leading consultancy firm specialising in the life sciences and healthcare sectors. Founded in 2015, the company has rapidly established itself as a trusted partner for pharmaceutical and biotechnology companies, offering a range of services that include market access, medical communications, and strategic consulting. With a strong presence in key operational regions across Europe and North America, Cello Health is renowned for its innovative approach to addressing complex industry challenges. The firm’s unique blend of scientific expertise and commercial insight enables clients to navigate the evolving healthcare landscape effectively. Notable achievements include a robust portfolio of successful client engagements and a commitment to delivering tailored solutions that drive value. Cello Health Limited continues to solidify its market position as a go-to resource for organisations seeking to enhance their impact in the competitive life sciences arena.
DitchCarbon Score
How does Cello Health Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cello Health Limited's score of 20 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cello Health Limited's reported carbon emissions
In 2023, Cello Health Limited reported carbon emissions of approximately 92,000 kg CO2e, an increase from about 59,000 kg CO2e in 2022. The emissions disclosed are solely from Scope 2, which pertains to indirect emissions from purchased electricity, steam, heating, and cooling. Currently, Cello Health has not established any specific reduction targets or initiatives, nor have they committed to the Science Based Targets initiative (SBTi). This lack of defined climate commitments may reflect a broader industry context where many companies are still developing their sustainability strategies. As Cello Health continues to assess its environmental impact, it is essential for the organisation to consider implementing measurable reduction strategies to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 59,000 | 00,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cello Health Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
